The periodontal inflamed surface area is associated with the clinical response to biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a retrospective study

References

• de Pablo P, Chapple ILC, Buckley CD, Dietrich T. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol. 2009;5(4):218–24.
   PubMed Web of Science ®Google Scholar
• Leech MT, Bartold PM. The association between rheumatoid arthritis and periodontitis. Best Pract Res Clin Rheumatol. 2015;29(2):189–201.
   PubMed Web of Science ®Google Scholar
• Potempa J, Mydel P, Koziel J. The case for periodontitis in the pathogenesis of rheumatic arthritis. Nat Rev Rheumatol. 2017;13(10):606–20.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Yoshie H. Host responses in the link between periodontitis and rheumatoud arthritis. Curr Oral Health Rep. 2015;2(1):1–8.
   PubMedGoogle Scholar
• Payne JB, Golub LM, Thiele GM, Mikuls TR. The link between periodontitis and rheumatoud arthritis: a periodontist’s perspective. Curr Oral Health Rep. 2015;2(1):20–9.
   PubMedGoogle Scholar
• McInnes IB, Buckley CD, Isaacs JD. Cytokines in rheumatic arthritis-shaping the immunological landscape. Nat Rev Rheumatol. 2016;12(1):63–8.
   PubMed Web of Science ®Google Scholar
• Kievit W, Fransen J, Oerlemans AJM, Kuper HH, van der Laar MAFJ, de Rooij DJRAM. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. Ann Rheum Dis. 2007;66(11):1473–8.
   PubMed Web of Science ®Google Scholar
• Schoels MM, van der Heijde D, Breedveld FC, Burmester GR, Dougados M, Emery P. Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement. Ann Rheum Dis. 2013;72(4):583–9.
   PubMed Web of Science ®Google Scholar
• Potter C, Hyrich KL, Tracey A, Lunt M, Plant D, Symmons DPM, et al. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumor necrosis factor response in rheumatoid arthritis. Ann Rheum Dis. 2008;68(1):69–74.
   PubMed Web of Science ®Google Scholar
• Klaasen R, Cantaert T, Wijbrandts CA, Teitsma C, Gerlag DM, Out TA, et al. The value of rheumatoid factor and anti-cyclic citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study. Rheumatology (Oxford). 2011;50(8):1487–93.
   PubMed Web of Science ®Google Scholar
• Pers Y-M, Fortunet C, Constant E, Lambert J, Godfrin-Valnet M, De Jong A, et al. Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice. Rheumatology (Oxford). 2014;53(1):76–84.
   PubMed Web of Science ®Google Scholar
• Kojima T, Yabe Y, Kaneko A, Hirano Y, Ishikawa H, Hayashi M, et al. Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis. Mod Rheumatol. 2013;23(5):977–85.
   PubMed Web of Science ®Google Scholar
• Okada M, Kobayashi T, Ito S, Yokoyama T, Komatsu K, Abe A, et al. Antibody response to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults. J Periodontol. 2011;82(10):1433–41.
   PubMed Web of Science ®Google Scholar
• Loutan L, Alpizar-Rodriguez D, Courvoisier DS, Finckh A, Mombelli A, Giannopoulou C. Periodontal status correlates with anti-citrullinated protein antibodies in first-degree relatives of individuals with rheumatoid arthritis. J Clin Periodontol. 2019;46(7):690–8.
   PubMed Web of Science ®Google Scholar
• Furuya T, Inoue E, Tanaka E, Maeda S, Ikari K, Taniguchi A, et al. Age and female gender associated with periodontal disease in Japanese patients with rheumatoid arthritis: results from self-reported questionnaires from the IORRA cohort study. Mod Rheumatol. 2019;In press. doi:10.1080/14397595.2019.1621461.
   Web of Science ®Google Scholar
• Savioli C, Ribeiro ACM, Fabri GMC, Calich AL, Carvalho J, Silva CA, et al. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis. J Clin Rheumatol. 2012;18(4):180–4.
   PubMed Web of Science ®Google Scholar
• Nesse W, Abbas F, van der Ploeg I, Spijkervet FKL, Dijkstra PU, Vissink A. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol. 2008;35(8):668–73.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Ito S, Kobayashi D, Kojima A, Shimada A, Narita I, et al. Interleukin-6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors. Clin Exp Dent Res. 2015;1(2):63–73.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(Suppl 1):S81–S90.
   PubMed Web of Science ®Google Scholar
• Funahashi K, Koyano S, Miura T, Hagiwara T, Okuda K, Matsubara T. Efficacy of tocilizumab and evaluation of clinical remission as determined by CDAI and MMP-3 level. Mod Rheumatol. 2009;19(5):507–12.
   PubMed Web of Science ®Google Scholar
• O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol. 1972;43(1):38.
   PubMed Web of Science ®Google Scholar
• Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21:533–51.
   PubMedGoogle Scholar
• Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ. Update of the case definitions for population-based surveillance of periodontitis. J Periodontol. 2012;83(12):1449–54.
   PubMed Web of Science ®Google Scholar
• Quirke A-M, Lugli EB, Wegner N, Hamilton BC, Charles P, Chowdhury M, et al. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis. 2014;73(1):263–9.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Ito S, Kobayashi D, Shimada A, Narita I, Murasawa A, et al. Serum immunoglobulin G levels to Porphyromonas gingivalis peptidylarginine deiminase affect clinical response to biological disease-modifying antirheumatic drug in rheumatoid arthritis. PLoS One. 2016;11(4):e0154182.
   PubMed Web of Science ®Google Scholar
• Nesse W, Linde A, Abbas F, Spijkervet FKL, Dijkstra PU, de Brabander EC, et al. Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol. 2009;36(4):295–300.
   PubMed Web of Science ®Google Scholar
• Temelli B, Yetkin Ay Z, Aksoy F, Büyükbayram HĬ, Kumbul Doğuç D, Uskun E, et al. Platelet indices (mean platelet volume and platelet distribution width) have correlations with periodontal inflamed surface area in coronary artery disease patients: a pilot study. J Periodontol. 2018;89(10):1203–12.
   PubMed Web of Science ®Google Scholar
• Harvey GP, Fitzsimmons TR, Dhamarpatni A, Marchant C, Haynes DR, Bartold PM. Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva. J Periodontal Res. 2013;48(2):252–61.
   PubMed Web of Science ®Google Scholar
• Bondt A, Hafkenscheid L, Falck D, Kuijper TM, Rombouts Y, Hazes JMW, et al. ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis. Ann Rheum Dis. 2018;77(8):1130–6.
   PubMed Web of Science ®Google Scholar
• Ohmi Y, Ise W, Harazono A, Takakura D, Fukuyama H, Baba Y, et al. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat Commun. 2016;7(1):11205.
   PubMedGoogle Scholar
• de Smit M, Westra J, Vissink A, Doornbos-van der Meer B, Brouwer E, van Winkelhoff AJ. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther. 2012;14(5):R222.
   PubMed Web of Science ®Google Scholar
• Pussinen PJ, Könönen E, Paju S, Hyvärinen K, Gursoy UK, Huumonen S, et al. Periodontal pathogen carriage, rather than periodontitis, determines the serum antibody levels. J Clin Periodontol. 2011;38(5):405–11.
   PubMed Web of Science ®Google Scholar
• Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000. 1994;5(1):78–111.
   Google Scholar
• Lappin DF, Apatzidou D, Quirke A-M, Oliver-Bell J, Butcher JP, Kinane DF, et al. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titers. J Clin Periodontol. 2013;40(10):907–15.
   PubMed Web of Science ®Google Scholar
• Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, et al. Disease activity score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis. 2007;66(9):1221–6.
   PubMed Web of Science ®Google Scholar
• Han JY, Reynolds MA. Effect of anti-rheumatic agents on periodontal parameters and biomarkers of inflammation: a systematic review and meta-analysis. J Periodontal Implant Sci. 2012;42(1):3–12.
   PubMed Web of Science ®Google Scholar
• Pocock JM, Vasconcelos JC, Östör AJK. Assessment of anti-TNF-α efficacy in rheumatoid arthritis: is 3 months sufficient?. Rheumatology (Oxford). 2008;47(7):1073–6.
   PubMed Web of Science ®Google Scholar